Research Article
Neutrophil-to-Lymphocyte Ratio in Ovarian Cancer Patients with Low CA125 Concentration
Table 5
Characterization of the different diagnostic methods for different study groups.
| | Positive# | Negative# | Total | Sensitivity | Specificity | PPV | NPV |
| Entire patient group | | | | | CA125>35 U/ml | | | | | | | Positive | 152 | 0 | 152 | 87.9% | 100% | 100% | 76.9% | Negative | 21 | 70 | 91 | Total | 173 | 70 | 243 | CA125 >24.55 U/ml and NLR>3.00 | | | | Positive | 66 | 0 | 66 | 38.2% | 100% | 100% | 39.5% | Negative | 107 | 70 | 177 | Total | 173 | 70 | 243 | CA125 >24.55 U/ml or NLR>3.00 | | | | | Positive | 160 | 15 | 175 | 92.5% | 78.6% | 91.4% | 80.9% | Negative | 13 | 55 | 68 | Total | 173 | 70 | 243 |
| Low concentration patient group | CA125>35 U/ml | Positive | 0 | 0 | 0 | 0% | 0% | 0% | 76.9% | Negative | 21 | 70 | 91 | Total | 21 | 70 | 91 | CA125 >7.65 U/ml and NLR>1.72 | | | | Positive | 11 | 23 | 34 | 52.4% | 67.1% | 32.4% | 82.5% | Negative | 10 | 47 | 57 | Total | 21 | 70 | 91 | CA125 >7.65 U/ml or NLR>1.72 | | | | | Positive | 21 | 61 | 82 | 100% | 12.9% | 25.6% | 100% | Negative | 0 | 9 | 9 | Total | 21 | 70 | 91 |
|
|
PPV: positive predictive value; NPV: negative predictive value; #: results based on pathology test.
|